Pandemic preparedness: toward a universal influenza vaccine
- PMID: 19330167
- DOI: 10.1358/dnp.2009.22.2.1334451
Pandemic preparedness: toward a universal influenza vaccine
Abstract
The possible emergence of a new influenza pandemic is considered a major threat for human health worldwide. Pandemics start by the introduction or reintroduction and spread in the human population of an influenza virus subtype against which almost nobody has protective immunity. Currently used influenza vaccines provide good protection only against antigenically matching influenza strains. However, neither the timing nor the subtype of the next pandemic virus is known. Therefore, different approaches are being pursued in anticipation of this pandemic threat. In the present article, we review approaches that aim to induce heterosubtypic immunity, that is, protection against challenge with influenza A viruses belonging to two or more subtypes. Experimental and epidemiological studies indicate that natural infection can provide some heterosubtypic immunity, possibly involving cellular immune responses directed against matrix and/or nucleoprotein as well as humoral responses against neuraminidase. Other approaches have focused on the use of conserved epitopes of the viral proteins, including matrix protein 2 ectodomain (M2e) and nucleoprotein (NP). Proof-of-concept of protection by these novel vaccines has been obtained in animal models, and promising results from several clinical trials have recently been reported. Demonstrating the efficacy of these new vaccines against a potential pandemic influenza endowed with human transmissibility remains a major challenge.
Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.
Similar articles
-
M2e-based universal influenza A vaccine.Vaccine. 2009 Oct 23;27(45):6280-3. doi: 10.1016/j.vaccine.2009.07.007. Vaccine. 2009. PMID: 19840661 Review.
-
Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.Cell Immunol. 2001 Aug 1;211(2):143-53. doi: 10.1006/cimm.2001.1835. Cell Immunol. 2001. PMID: 11591118
-
Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.Jpn J Infect Dis. 2005 Aug;58(4):195-207. Jpn J Infect Dis. 2005. PMID: 16116250 Review.
-
Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.Vaccine. 2006 Jun 12;24(24):5158-68. doi: 10.1016/j.vaccine.2006.04.008. Epub 2006 May 2. Vaccine. 2006. PMID: 16713037
-
Vaccines to protect humans from pandemic avian influenza strains.Md Med. 2006 Winter;7(1):15-8. Md Med. 2006. PMID: 16613361 Review.
Cited by
-
Development of a universal CTL-based vaccine for influenza.Bioengineered. 2013 Nov-Dec;4(6):374-8. doi: 10.4161/bioe.23573. Epub 2013 Jan 21. Bioengineered. 2013. PMID: 23337287 Free PMC article. Review.
-
Induction of cross-protection against influenza A virus by DNA prime-intranasal protein boost strategy based on nucleoprotein.Virol J. 2012 Nov 23;9:286. doi: 10.1186/1743-422X-9-286. Virol J. 2012. PMID: 23173785 Free PMC article.
-
Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections.PLoS One. 2010 May 11;5(5):e10583. doi: 10.1371/journal.pone.0010583. PLoS One. 2010. PMID: 20485501 Free PMC article.
-
Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.Microb Cell Fact. 2015 Aug 5;14:111. doi: 10.1186/s12934-015-0287-4. Microb Cell Fact. 2015. PMID: 26242406 Free PMC article.
-
Intranasal immunization with influenza antigens conjugated with cholera toxin subunit B stimulates broad spectrum immunity against influenza viruses.Hum Vaccin Immunother. 2014;10(5):1211-20. doi: 10.4161/hv.28407. Epub 2014 Mar 14. Hum Vaccin Immunother. 2014. PMID: 24632749 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous